Parkinson's Disease Trial, Not Yet Recruiting NCT07675408 Sponsor: Fortis Medical Devices Limited Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Not Yet Recruiting

NCT07675408
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged between 60 and 90 years old (inclusive)
  • People who have been diagnosed with idiopathic Parkinson's disease (Parkinson's that develops on its own, not caused by another condition), confirmed by a neurologist or doctor, and verified through medical records and an in-clinic assessment
  • People who are able to walk 12 metres without a walking frame or similar aid (a cane used in daily life is permitted)
  • People who are currently taking levodopa (a common Parkinson's medication), and whose Parkinson's medications have not changed for at least four weeks before the screening visit, with no changes expected during the study
  • People who score 22 or higher on a standard memory and thinking test called the Montreal Cognitive Assessment (MoCA)
  • People who have completed a standard neurological examination as assessed by a study clinician
  • People who show a certain level of "freezing of gait" (a symptom where walking suddenly stops) during a specific in-clinic test, as measured by independent trained reviewers analysing video recordings (confirm with trial site for exact threshold details)

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People whose Parkinson's symptoms are caused by another condition, such as reduced blood flow to the brain (vascular parkinsonism), or who have an atypical form of parkinsonism
  • People with a history of dementia, severe depression, psychosis, or who are currently experiencing hallucinations
  • People with a history of migraines, tinnitus (ringing in the ears), seizures, or significant sensory problems
  • People with another neurological or bone/joint condition that significantly affects the way they walk
  • People who have used a cueing device (a device designed to help with movement) within the last three months
  • People who have an implanted electronic device, such as a deep brain stimulation (DBS) device
  • People who use assistive devices that are not compatible with the trial device (confirm with trial site)
  • People who are currently taking part in another clinical trial
  • People whom the trial investigator considers unsuitable for any reason
  • People whose medical records show that any of the following occurred within the last three months: heart attack, hospitalisation for unstable chest pain (angina), stroke, heart bypass surgery, a procedure to open blocked heart arteries, implantation of a heart rhythm device, active cancer treatment, uncontrolled heart failure (at a severity above NYHA class 3), acute psychosis, major psychiatric disorders, or ongoing substance misuse
  • Women who are pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Fortis Medical Devices Limited
Registry
ClinicalTrials.gov
Start date
1 October 2026
Est. completion
1 February 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Demonstrate Superiority

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov